How Online Businesses Can Scale, Improve and Maximize Profitability — Even in a Volatile Economy
Today's unpredictable business environment makes it essential for ecommerce entrepreneurs to recognize key operational tipping points — like automation, order volume growth and multichannel complexity — and adopt the right tools to scale efficiently, protect margins and meet customer expectations.
Opinions expressed by Entrepreneur contributors are their own.
The entrepreneur's journey is rife with ups and downs and zigs and zags, regardless of whether you're just starting out or you've scaled your brand into an enterprise operation. Today's nerve-wracking rollercoaster business landscape is a case in point. With the dizzying pace of tariff changes from the current administration and the volatility of market reactions, ecommerce business owners are bobbing and weaving to limit exposure and safeguard margins.
It's entirely likely that trade curveballs will continue to fly throughout 2025, creating uncertainty and profitability concerns for ecommerce brands and omnichannel retailers across every industry. In the face of this retail precarity, understanding the critical tipping points of your ecommerce operations — and what questions you need to ask at each stage — is an integral step for scaling growth, building stability and protecting the bottom line in any economy.
Related: 5 Trends Influencing the Future of Ecommerce
Tipping point: Simple automation with software
Your basement is piled high with inventory and you've roped the entire family into packing orders. Does this sound familiar? Unfortunately, the all-hands-on-deck bootstrap approach to the start-up phase of building an online business is not sustainable as you gain traction.
Given the limits of a basic ecommerce platform, manual label printing, and consumer-grade shipping tools — not to mention your rudimentary inventory management system (a.k.a. an Excel spreadsheet) — the need to automate aspects of fulfillment becomes apparent.
At this point, your ecommerce business has reached a critical inflection point, leaving many entrepreneurs wondering where to start. Begin by considering the following:
What's the simplest way to fulfill orders for my customers? How do I print labels? Which shipping partner should I choose? How should I charge for shipping? What's my delivery promise?
Simple integrated software can make a world of difference to your daily workload. Consider bulk label printing and basic shipping software with pre-negotiated rates and standardized shipping options. With these tools, you can eliminate the need to manually enter and update information in your shipping system, saving time and improving inventory accuracy.
Related: 5 Things to Know Before Launching a New Product
Tipping point: Order volume growth
As your sales grow to 20-100+ orders per day, revenue becomes more predictable and the focus shifts to creating efficiencies in your business. Due to storage constraints and the need to meet customer expectations for on-time delivery, fulfilling orders out of the home is no longer the efficient or cost-effective choice.
Think about:
Is it time to move inventory to a warehouse? To scale inventory and keep pace with growing customer demand, consider moving inventory to a small warehouse. Alternatively, outsourcing fulfillment using a third-party logistics (3PL) provider is an option; if you sell via online marketplaces such as Amazon or Walmart, you could consider services like Fulfilled by Amazon (FBA) or Walmart Fulfillment Services (WFS). What processes can I automate to increase efficiency? For example, automating the selection of carrier and shipping service using shipping software with real-time rate shopping can help you reduce transportation costs while enabling you to keep your delivery promise to enhance your brand reputation.
As your business scales to 500-1,000+ orders per day, the need for and dependence on people to manage volumes becomes a growing challenge. Your warehouse can also become a bottleneck, impeding fulfillment speed and negatively impacting the customer experience. Relying on a manual pick-pack-ship workflow slows down order processing and increases the risk of errors. Plus, as SKU count expands, better warehouse space utilization is crucial for optimizing picking speed and accuracy.
This volume-driven tipping point necessitates the transition to an automated warehouse management system (WMS) to simplify and accelerate order fulfillment. It's time to ask:
Is my warehouse running as efficiently as it can? Am I dependent on new warehouse staff to grow shipping volume? Are they properly trained on picking and dispatch workflows and returns management processes? Consider implementing advanced warehouse optimization and automation strategies on the warehouse floor — barcode scanning, multi-order picking, system-driven walking routes, task-based replenishment and automated carrier selection — to save time and labor costs while improving order accuracy and inventory control.
For all of your single-item orders, consider batch shipping to reduce complexity to get more orders out the door faster. Keep in mind that returns also rise with increased order volumes. It's time to think about returns management more strategically by introducing a tech-supported process that simplifies and expedites returns for customers and operations. Is our team ready to handle peak? Periodic seasonal or event-driven spikes in order volume can overwhelm operations if you're not prepared, crippling fulfillment efforts and frustrating customers. By removing paper and manual processes from the pick-pack-ship workflow, your team can scale quickly and seamlessly during peak periods. In the same vein, inventory forecasting is a valuable strategy at this stage to enhance inventory control. Consider implementing demand planning tools to prevent stockouts or overstock. How should I optimize my carrier contracts and relationships? It's easy to get complacent with carrier selection when you're distracted by keeping the warehouse running smoothly as order volumes escalate. But reviewing carrier contracts and negotiating better carrier rates on an annual basis can cut shipping costs and make sure you're getting the best services for your needs. How could 3PLs supplement my own distribution center (DC)? If you've relied solely on in-house fulfillment up to this point, consider the benefits of 3PL partnerships. For example, perhaps it's more efficient and cost-effective to service the East Coast with your local DC and fleet while outsourcing to a 3PL partner to manage fulfillment for West Coast customers.
Related: Scaling Isn't About Flashy Ideas — It's About Process. 8 Steps to Get It Right
Tipping point: Sales channel diversity
Selling on multiple channels brings unique challenges, whether you're just starting out selling items through your website and eBay, or whether you're a seasoned direct-to-consumer (D2C) pro, shipping thousands of items daily via Amazon, Walmart and Wayfair.
Regardless of your multichannel model, the primary challenges and risks — centered around the complexity of managing inventory efficiently and accurately across multiple channels to meet fulfillment demands — are the same: overselling (translates to unhappy customers) and overstocking (ties up capital and valuable warehouse space).
Without the right systems and technology in place to sync multichannel sales activity, inventory management can easily go off the rails. Review your approach to order processing across the different marketplaces and distribution channels and how it impacts the customer experience:
How do I organize and keep track of inventory across multiple channels as sales take off? Regardless of the complexity of your sales channel diversity, implementing an integrated order management system (OMS) to consolidate orders from multiple channels and marketplaces is critical to ensure order accuracy and improve inventory control. Is my warehouse team ready to process orders from multiple marketplaces and/or sales channels in an efficient manner? Have we considered the additional workload that is created by adding a new channel? Are there additional steps or new requirements to consider and is my warehouse team proficient in executing necessary workflows with agility to meet customer demand? How do I balance profitability with customer delivery expectations? Omnichannel consistency is vital for building brand loyalty and driving repeat business. By syncing stock across all sales channels in real time — coupled with an integrated returns management system — you can protect margins while meeting your delivery promise to customers, regardless of whether they purchased items from your website, Amazon or other online marketplaces.
Recognizing the critical operational tipping points ecommerce businesses face is fundamental to managing the operational and growth factors that are within your control. By asking the right questions, you'll be better equipped to optimize operations at each stage and implement the best tools and technologies to build scalable processes, satisfy customer expectations and sustain profitability amidst tariff commotion and economic volatility.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
40 minutes ago
- Yahoo
2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts
These biotech companies have several catalysts ahead -- and in the past have soared on good news. They both offer innovative candidates that could result in game-changing treatments for patients. 10 stocks we like better than Viking Therapeutics › If you're looking to add growth to your portfolio, biotech stocks can be a great choice. Exciting research is happening in these companies' labs, and in some cases, game-changing treatment candidates are approaching important milestones or even going over the finish line. As an investor in these companies, you can benefit as they report positive clinical trial news, score a regulatory approval, or start generating product revenue. Wall Street considers two candidates extremely compelling right now, with forecasts for potential gains of more than 80% and 200% in the coming 12 months. One of these players is working in the high-growth area of weight loss drugs, and the other candidate showed its strengths by winning the world's first-ever approval of a product based on CRISPR gene editing. Let's check out these two biotech stocks to buy before they skyrocket. Viking Therapeutics (NASDAQ: VKTX) soared early last year when it reported strong data from the phase 2 trial of its weight loss candidate, VK2735, but the stock has since given back those gains and is trading closer to the level it was at prior to that data announcement. Since, the company has continued to advance VK2735 in injectable form and a version in pill form, and demand for these sorts of drugs remains high -- these are two reasons to believe that Viking has the potential to take off again. And catalysts may be on the horizon. The drug works in a manner similar to Eli Lilly's blockbuster tirzepatide, sold under the names Mounjaro and Zepbound. These drugs interact with hormones involved in digestion and have helped people quickly and safely lose weight. Viking is beginning the phase 3 trial for injectable VK2735 in the second quarter and expects data from its phase 2 trial of the pill version in the second half. Any data announcements could result in big moves for the stock, as there is plenty of room for a new company to enter the weight loss drug market -- one forecast to approach $100 billion in a few years. Wall Street is optimistic about Viking's prospects, with the average price forecast predicting an increase of about 240% in the stock price from today's level. Of course, Viking depends heavily on the outcome of these trials, so some risk is involved -- but data have been strong, so growth investors may want to get in on Viking now to potentially post a big win later. CRISPR Therapeutics (NASDAQ: CRSP) stock surged in the year leading up to a major milestone: its first product approval. But since last year's launch of Casgevy, a gene-editing treatment for blood disorders, the stock has been on the decline. Sometimes, investors buy a stock well before the company wins approval or launches a product, then lock in gains after the good news lands -- and I think this is what's happened here. But what this does is offer us a chance to get in at a very good price on a promising company that could deliver fantastic news down the road. Casgevy, as a gene-editing treatment, requires a longer time to roll out than a pill or injection, as it includes several steps that happen over a period of months. The company recently said new patient initiations should increase "significantly" this year -- so there's reason to be optimistic about revenue growth ahead. CRISPR Therapeutics also recently reported positive phase 1 data for a gene editing candidate addressing the problem of high cholesterol. And the company expects to report data soon from a phase 1 trial of a candidate targeting patients with elevated levels of lipoprotein(a) -- a risk factor for cardiovascular events. These could represent huge markets for CRISPR Therapeutics if the candidates reach the finish line, and in the meantime, any potential positive news could boost the stock. The company also expects other trial updates in candidates for oncology and autoimmune diseases this year -- so this biotech's calendar is full of possible catalysts. Wall Street's average price forecast calls for an 84% gain for CRISPR Therapeutics from today's price -- if all goes well in clinical trials and Casgevy starts to show revenue growth, now could represent a golden buying opportunity for growth investors. Before you buy stock in Viking Therapeutics, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Viking Therapeutics wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $664,089!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $881,731!* Now, it's worth noting Stock Advisor's total average return is 994% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Adria Cimino has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends CRISPR Therapeutics. The Motley Fool recommends Viking Therapeutics. The Motley Fool has a disclosure policy. 2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
43 minutes ago
- Yahoo
Dan Ives Says Market Is 'Massively Underestimating' This AI Play, Urges Investors To Look Beyong Mag 7
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Dan Ives' new artificial intelligence exchange-traded fund (ETF) holds securities beyond the Magnificent 7 stocks, as he believes in looking past valuations for investments in the technology sector. What Happened: The Dan IVES Wedbush AI Revolution ETF (NYSE:IVES), managed by the Wedbush analyst, started trading on June 4, earlier this month. Ives boasts of the fund by saying that it just doesn't have the top four, five Magnificent 7 names, but stocks which investors wouldn't even thematically consider as an AI name today. "I believe the market is still massively underestimating what the growth is going to look like for the AI revolution in tech," he told CNBC. Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — According to him, tech trade remains significant even for the investors who missed out on its growth in the past few years. "If you focus just on valuation, you miss every transformational tech stock of the last 20 years," Ives said. Ives says Oracle Corp. (NYSE:ORCL) will be the 'epicenter' of the AI theme, while highlighting other 'AI 30' stocks which are part of his fund. Palantir Technologies Inc. (NASDAQ:PLTR), International Business Machines Corp. (NYSE:IBM), Salesforce Inc. (NYSE:CRM), SoundHound AI Inc. (NASDAQ:SOUN), and Innodata Inc. (NASDAQ:INOD) are a few notable names that are a part of his ETF's 'AI 30' basket. Microsoft Corp. (NASDAQ:MSFT), Nvidia Corp. (NASDAQ:NVDA), and Broadcom Inc. (NASDAQ:AVGO) are the top three holdings of the IVES It Matters: The 'AI 30' stocks, which are a part of the IVES ETF, hold the AI plays from multiple industries. They include hyperscalers, cybersecurity, consumer platforms, and robotics. According to Ives, the list was compiled from his deep dives into major AI players. The ETF has $183 million in assets under management as of June 17 close. Ives said that the AI space was experiencing a "golden age." The Dan IVES Wedbush AI Revolution ETF has risen by 2.76% since its inception. A comparable index, S&P Kensho Global Artificial Intelligence Enablers, rose 6.08% on a month-to-date basis. Meanwhile, the SPDR S&P 500 ETF Trust (NYSE:SPY) and Invesco QQQ Trust ETF (NASDAQ:QQQ), which track the S&P 500 index and Nasdaq 100 index, respectively, declined slightly on Wednesday. The SPY was down 0.015% at $597.44, while the QQQ was 0.017% lower at $528.99, according to Benzinga Pro data. Read Next: Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. Back a bold new approach to cancer treatment with high-growth potential. If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it? Photo courtesy: Shutterstock This article Dan Ives Says Market Is 'Massively Underestimating' This AI Play, Urges Investors To Look Beyong Mag 7 originally appeared on
Forbes
44 minutes ago
- Forbes
Google's Quiet Confirmation Of The Pixel 10
Google's "Talking Phones Podcast" title card Google is having a little bit of fun in its latest iPhone vs Pixel video. While the Pixel 9 Pro takes pride of place, there's also a surprising cameo for what comes next… the Pixel 10. The Pixel 10 Easter Egg The details come at the end of Google's latest promotional video posted on its Made By Google YouTube channel. In it, an iPhone and a Pixel talk about the recent advances made by Apple's smartphone, with a not at all surprised Pixel noting when that feature arrived on Pixel and Android. These include live translation, hold assistance and call screening arriving four, five and seven years ago respectively., Of course, the capabilities of all these features have improved significantly over the last few years, so there are shades of Oranges to (ahem) Apples here, but it makes Google's point effectively. The story of Android being ahead of iOS is here for all to hear. The little easter egg at the end is part of another story, leading into the next Pixel release. The iPhone quietly asks the Pixel 9 Pro, 'so, what are you working on for Pixel 10… just out of curiosity?' Naming The Pixel 10 It's no secret that Google is working on the next family of Pixel smartphones. Neither is it a secret that we're expecting an entry-level Pixel 10, a premium Pixel 10 Pro, a larger Pixel 10 Pro XL and an innovative Pixel 10 Pro Fold. Yet this is the first time Google has publicly acknowledged that the new handsets will carry the Pixel 10 branding. Although the sharp-eared watchers will note that it was the iPhone confirming the new Pixel 10, not the Pixel 9 Pro. So, did Apple confirm the new name, rather than Google? Google is expected to announce the Pixel 10 family at an upcoming Made By Google event. While dates have not been confirmed, talk within the community picks out Wednesday, Aug. 20 for the launch, and Thursday, Aug 28. for the first handsets to go on sale to the public. Now read how the Pixel 10 will impact every Android smartphone in 2025 and beyond…
